The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

12 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Designed multiple ligands. An emerging drug discovery paradigm.EBI
Organon Laboratories
Anionic cyclophanes as potential reversal agents of muscle relaxants by chemical chelation.EBI
Organon Laboratories
Novel piperidinium and pyridinium agents as water-soluble acetylcholinesterase inhibitors for the reversal of neuromuscular blockade.EBI
Organon Laboratories
Quaternary salts of E2020 analogues as acetylcholinesterase inhibitors for the reversal of neuromuscular block.EBI
Organon Laboratories
Synthesis of novel analogues of the delta opioid ligand SNC-80 using REM resin.EBI
Organon Laboratories
Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative properties.EBI
Organon Laboratories
Synthesis and SAR studies of 3-phenoxypropyl piperidine analogues as ORL1 (NOP) receptor agonists.EBI
Organon Laboratories
Identification of"latent hits" in compound screening collections.EBI
Organon Laboratories
Oxyaniliniums as acetylcholinesterase inhibitors for the reversal of neuromuscular block.EBI
Organon Laboratories
The first potent and selective inhibitors of the glycine transporter type 2.EBI
Organon Laboratories
Synthesis of novel analogues of the delta opioid ligand SNC-80 using AlCl3-promoted aminolysis.EBI
Organon Laboratories
Structure-activity relationships and CoMFA of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic properties.EBI
Organon Laboratories